🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Giuseppe Tarantino

Broad Institute

ORCID: 0000-0002-6078-6856

Also affiliated with Boston University, Marche Polytechnic University, Harvard University, Ospedali Riuniti di Ancona, Dana-Farber Cancer Institute, Cancer Research Center, University of Bologna

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming”.

DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0634

N/A

0.596DataRank · unranked

16 citations

Jinkai Wan, Vajira Weeresekara, Joel Markus Vaz, Giuseppe Tarantino, Tenna Holgersen Bryde +19 more

The dynamics of hematopoiesis over the human lifespan

Nature Methods(2024)10.1038/s41592-024-02495-0

N/A

0.489DataRank · unranked

25 citations

Parker Côté, Michael Kuoch, Jideofor Ezike, Katie Frenis, Anton Afanassiev +25 more

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506051

N/A

0.300DataRank · unranked

4 citations

Alvin Shi, Ming Tang, Marcus Ho, Christopher Terranova, Kyriaki Galani +36 more

Circulating cytokine associations with clinical outcomes in melanoma patients treated with combination nivolumab plus ipilimumab

OncoImmunology(2024)10.1080/2162402x.2024.2432723

N/A

0.292DataRank · unranked

6 citations

Giuseppe Tarantino, Mariano Severgnini, Joanna Bagińska, Anita Giobbie‐Hurder, Jason L. Weirather +14 more

Stratified analysis identifies HIF-2 α as a therapeutic target for highly immune-infiltrated melanomas

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.29.620300

N/A

0.231DataRank · unranked

3 citations

Kelly P. Burke, Ryan Porter, Lynn Meiger, Peter Fatouros, Jiekun Yang +24 more

Defensive tolerance drives the reprogramming and dysfunction of infiltrating pathogenic B cells assuring the maintenance of tolerance

Research Square(2025)10.21203/rs.3.rs-7236564/v1

N/A

0DataRank · unranked

0 citations

Koki Hayashi, Takahiro Yokose, Jenna Lancey, Edward S. Szuter, Brandon Kwon +28 more

2017 – HUMAN HEMATOPOIETIC STEM CELL ONTOGENY ACROSS DEVELOPMENT AND MATURATION

Experimental Hematology(2022)10.1016/j.exphem.2022.07.049

N/A

0DataRank · unranked

0 citations

Hojun Li, Parker Cote, Michael Kuoch, Jideofor Ezike, Anton Afanassiev +22 more

Leveraging longitudinal clinical annotations and panel sequencing to characterize dynamics of organotropism in metastatic melanoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9526

N/A

0DataRank · unranked

0 citations

Michael P. Manos, William Ge, Giuseppe Tarantino, Xue Bai, Osama E. Rahma +5 more

Overcoming Resistance Mechanisms to Melanoma Immunotherapy

American Journal of Clinical Dermatology(2024)10.1007/s40257-024-00907-7

N/A

0DataRank · unranked

19 citations

David J. Bozym, Giuseppe Tarantino, Ryan J. Sullivan, David Liu, Russell W. Jenkins +1 more